Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival.

Date publication

juillet 2019

Journal

Respiratory medicine and research

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier

Tous les auteurs :
Asselain B, Barrière JR, Clarot C, Vabre JP, Gentil Le Pecq B, Duval Y, Thomas P, Herman D, Grivaux M, Debieuvre D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31527016

Résumé

Patients with metastatic non-small-cell lung cancer (NSCLC) who survive more than 2 years are considered long-term survivors (LTSs). The present study examined factors associated with long-term survival and collected information for future comparison.

Mots clés

Cancer survivors, Carcinoma, General hospitals, Non-small-cell lung, Observational study, Prognosis factors

Référence

Respir Med Res. 2019 Jul 10;76:38-44